Tranexamic acid (Cyclocapron, Kabi) . An antifibrinolytic
Storm, O.
Ugeskrift for Laeger 137(20): 1120-1121
1975
ISSN/ISBN: 0041-5782 PMID: 1136002 Document Number: 86071
Document emailed within 1 workday
Related Documents
Rutqvist, L.E.; Bolund, C.; Friberg, S.; Einhorn, N.; Wallgren, A. 1977: Treatment of advanced cancer with Cyclocapron (tranexamic acid) Lakartidningen 74(32): 2679-2680Hansen, P.E.; Hansen, J.H.; Bramsen, T. 1982: Cerebral disseminated lupus erythematosus treated with tranexamic acid (Cyclocapron) Ugeskrift for Laeger 144(31): 2289-2290
Kjellman, H.; Schannong, M. 1970: Tranexamic acid, a new antifibrinolytic agent Nordisk Medicin 83(6): 166-168
Marmo, E.; Ungaro, B.; Giordano, L. 1971: On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid) Minerva Cardioangiologica 19(2): 86-115
Waly, N.G. 1995: Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions Egyptian Dental Journal 41(1): 961-968
Maineri, P.; Covaia, G.; Realini, M.; Caccia, G.; Ucussich, E.; Luraschi, M.; Crosta, A.; Foresti, B.; Chiaranda, M. 2000: Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid Minerva Cardioangiologica 48(6): 155-160
Desai, S.; Ayres, E.; Bak, H.; Manco, M.; Lynch, S.; Raab, S.; Du, A.; Green, D.; Skobowiat, C.; Wangari-Talbot, J.; Zheng, Q. 2019: Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: a Clinical Evaluation Journal of Drugs in Dermatology: Jdd 18(5): 454-459
Godal, H.C. 1991: Rational use of tranexamic acid Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(18): 2274-2275
Tscheikuna, J.; Chvaychoo, B.; Naruman, C.; Maranetra, N. 2002: Tranexamic acid in patients with hemoptysis Journal of the Medical Association of Thailand 85(4): 399-404
Gårskjaer, F.; Nepper-Rasmussen, Jørgen. 2006: Tranexamic acid and subarachnoid hemorrhage Ugeskrift for Laeger 168(18): 1777; Author Reply 1777
Gram, Jørgen. 2009: Tranexamic acid and dentoalveolar surgery Ugeskrift for Laeger 171(21): 1801; Author Reply 1801
Ali, I.M.; Landymore, R.W. 1994: The use of tranexamic acid in cardiac operations Journal of Thoracic and Cardiovascular Surgery 107(5): 1377
Srinil, S.; Jaisamrarn, U. 2005: Treatment of idiopathic menorrhagia with tranexamic acid Journal of the Medical Association of Thailand 88(Suppl 2): S1-S6
Hoste, S.; Van Aken, H.; Stevens, E. 1991: Tranexamic acid in the treatment of anaphylactic shock Acta Anaesthesiologica Belgica 42(2): 113-116
Jericó-Pascual, I.; Gállego-Cullere, J. 2008: Stroke, tranexamic acid and patent foramen ovale Revista de Neurologia 46(3): 186
Zachariae, H.; Laurberg, G.; Hjortshoj, A. 1975: Tranexamic acid (Cyclokapron) in hereditary angioneurotic edema Ugeskrift for Laeger 137(20): 1106-1108
Humbert, P.; Gutknecht, J.; Mallet, H.; Dupond, J.L.; Leconte des Floris, R. 1987: Tranexamic acid and thrombosis of the superior longitudinal sinus Therapie 42(1): 65-66
Sundbeck, A.; Alpsten, M.; Appelgren, L.; Karlsson, L.; Månsson, L.G.; Peterson, H.I. 1981: Influence of tranexamic acid on tumour blood flow Anticancer Research 1(3): 141-148
Dussel, J.N.; Zdankiewicz, P. 2015: Tranexamic acid: familiarity and use in the Level Ii trauma hospital American Surgeon 81(1): E10-E11
Puigdellívol, E.; Carral, M.E.; Moreno, J.; Plà-Delfina, J.M.; Jané, F. 1985: Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man International Journal of Clinical Pharmacology Therapy and Toxicology 23(6): 298-301